Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [11365]

SABCS 2015: Capecitabine improved outcomes for breast cancer patients with residual disease after presurgery chemotherapy

SABCS 2015: Capecitabine improved outcomes for breast cancer patients with residual disease after presurgery...

SABCS 2015: Women with luminal a subtype of breast cancer did not benefit from adjuvant chemotherapy

SABCS 2015: Women with luminal a subtype of breast cancer did not benefit from adjuvant chemotherapy

SABCS 2015: Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer

SABCS 2015: Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer

Scientists investigate molecular processes for targeted dog cancer therapy

Scientists investigate molecular processes for targeted dog cancer therapy

$ASH 2015: Results from phase 2 study for treatment of relapsed or refractory hodgkin lymphoma following autologous stem cell transplantation$

ASH 2015: Results from phase 2 study for treatment of relapsed or refractory hodgkin lymphoma following autologous...

$ASH 2015: Carfilzomib superior to bortezomib in relapsed and refractory multiple myeloma$

ASH 2015: Carfilzomib superior to bortezomib in relapsed and refractory multiple myeloma

Brazilian court cuts cancer patients’ access to treatment untested in clinical trials

Brazilian court cuts cancer patients’ access to treatment untested in clinical trials

New toolkit for primary care professionals

New toolkit for primary care professionals

Children’s cancer death rates drop by a quarter in 10 years

Children’s cancer death rates drop by a quarter in 10 years

Researchers discover how immune cells resist radiation treatment

Researchers discover how immune cells resist radiation treatment

More from ecancer